Scaling with organoids: Implementing patient-derived organoid models in high-throughput workflows

Producing patient-derived organoids (PDOs) at scale has become a major bottleneck in adopting these models for high-throughput and repeat-use applications such as pooled CRISPR screening, hit-to-lead screening, and compound screening. Traditional culture methods are slow, labor-intensive, and often yield inconsistent organoid models, making it difficult to meet the demands of these applications.

In this eBook, we explore these challenges in depth and share proven strategies to help you scale up your organoid research. Learn how to obtain consistent, high-quality PDOs and integrate them seamlessly into high-throughput assays.